AMLX

Amylyx Pharmaceuticals is a drug company developing treatments for rare diseases and conditions affecting the nervous system and metabolism. The company is testing several experimental drugs, including one for a dangerous drop in blood sugar that can occur after weight-loss surgery, and another for a rare genetic disorder that damages the brain and pancreas. Most of its drugs are still in early stages of testing in patients and have not yet been approved by regulators.